Abcam, ab252724, Anti-Norovirus GII.4+GII.1+GII.2 antibody [B1936M]

Size: 250µg
Mouse Monoclonal Norovirus GII.4 antibody. Carrier free. Suitable for ELISA and reacts with Norovirus samples. Cited in 1 publication. Immunogen corresponding to Virus preparation containing Norovirus GII.4 protein.
Key facts
Host species:Mouse,
Clonality:Monoclonal,
Clone number:B1936M,
Isotype:IgG1,
Light chain type:kappa,
Carrier free:Yes,
Reacts with:Norovirus,
Applications:ELISASee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Immunogen:The exact immunogen used to generate this antibody is proprietary information.

Properties and Storage Information:
Form-Liquid, Purification technique-Affinity purification Protein A, Purification notes-Purified from tissue culture supernatant. > 95% pure (size-exclusion chromatography)., Storage buffer-Constituents: PBS, Shipped at conditions-Blue Ice, Appropriate short-term storage duration-1-2 weeks, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions--20°C, Aliquoting information-Upon delivery aliquot, Storage information-Avoid freeze / thaw cycle

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
Norovirus GII.4+GII.1+GII.2 represents a combination of genotypes within the Norovirus family known for causing acute gastroenteritis. Genotype GII.4 is the most significant in terms of infection rate while GII.1 and GII.2 contribute to the genetic diversity of noroviruses. Structurally the norovirus capsid protein also known as the major capsid protein (VP1) has a mass of approximately 58 kDa. This viral capsid protein expresses predominantly in the small intestine of infected humans where it facilitates attachment and entry into host cells leading to infection.
Biological function summary
Norovirus genotypes contribute to the effective spread and persistence of the virus in human populations. The virus evolves rapidly with frequent mutations and recombination events enabling it to escape immune detection and sustain infection. It is not part of any complex but interacts directly with host cell receptors to mediate viral entry. The ability of norovirus to adapt quickly to environmental pressures makes it a significant agent in outbreaks of gastroenteritis worldwide.
Pathways
Norovirus infection involves several key biological processes including immune evasion and host cell lysis. Noroviruses manipulate the host's innate immune pathways impacting cytokine signaling and immune cell activation. The target relates closely to the innate immune receptors such as Toll-like receptors which play a significant role in recognizing viral components and initiating immune responses. Furthermore the NLRP3 inflammasome recognizes norovirus structures leading to immune cell activation and is a related protein through these pathway interactions.
Norovirus genotypes are closely linked to acute gastroenteritis and related complications including dehydration and electrolyte imbalances. Noroviruses cause significant morbidity worldwide especially in vulnerable populations like children and the elderly. The virus's interaction with cellular pathways involving the innate immune system proteins such as interferon regulatory factors contributes to its pathogenicity. Understanding norovirus's impact helps in designing vaccines and therapeutic interventions to manage outbreaks and reduce the disease burden.